Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study

Background: Physical activity might attenuate inflammation and neurodegeneration in multiple sclerosis (MS). Erythropoietin, which is produced upon exposure to hypoxia, is thought to act as a neuroprotective agent in MS. Therefore, we studied the effects of intermittent hypoxic training on activity...

Full description

Bibliographic Details
Main Authors: Anja Mähler, Andras Balogh, Ilona Csizmadia, Lars Klug, Markus Kleinewietfeld, Jochen Steiniger, Urša Šušnjar, Dominik N. Müller, Michael Boschmann, Friedemann Paul
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02819/full
id doaj-2c7e662b810a44f0a1148c6a909cf706
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Anja Mähler
Anja Mähler
Anja Mähler
Andras Balogh
Andras Balogh
Andras Balogh
Andras Balogh
Ilona Csizmadia
Lars Klug
Lars Klug
Markus Kleinewietfeld
Jochen Steiniger
Urša Šušnjar
Urša Šušnjar
Dominik N. Müller
Dominik N. Müller
Dominik N. Müller
Dominik N. Müller
Michael Boschmann
Michael Boschmann
Friedemann Paul
Friedemann Paul
Friedemann Paul
spellingShingle Anja Mähler
Anja Mähler
Anja Mähler
Andras Balogh
Andras Balogh
Andras Balogh
Andras Balogh
Ilona Csizmadia
Lars Klug
Lars Klug
Markus Kleinewietfeld
Jochen Steiniger
Urša Šušnjar
Urša Šušnjar
Dominik N. Müller
Dominik N. Müller
Dominik N. Müller
Dominik N. Müller
Michael Boschmann
Michael Boschmann
Friedemann Paul
Friedemann Paul
Friedemann Paul
Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study
Frontiers in Immunology
multiple sclerosis
hypoxia
endurance training
walking ability
energy metabolism
Tregs
author_facet Anja Mähler
Anja Mähler
Anja Mähler
Andras Balogh
Andras Balogh
Andras Balogh
Andras Balogh
Ilona Csizmadia
Lars Klug
Lars Klug
Markus Kleinewietfeld
Jochen Steiniger
Urša Šušnjar
Urša Šušnjar
Dominik N. Müller
Dominik N. Müller
Dominik N. Müller
Dominik N. Müller
Michael Boschmann
Michael Boschmann
Friedemann Paul
Friedemann Paul
Friedemann Paul
author_sort Anja Mähler
title Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study
title_short Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study
title_full Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study
title_fullStr Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study
title_full_unstemmed Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study
title_sort metabolic, mental and immunological effects of normoxic and hypoxic training in multiple sclerosis patients: a pilot study
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-11-01
description Background: Physical activity might attenuate inflammation and neurodegeneration in multiple sclerosis (MS). Erythropoietin, which is produced upon exposure to hypoxia, is thought to act as a neuroprotective agent in MS. Therefore, we studied the effects of intermittent hypoxic training on activity energy expenditure, maximal workload, serum erythropoietin, and immunophenotype focusing on regulatory and IL-17A-producing T cells.Methods: We assigned 34 relapsing-remitting MS patients within a randomized, single blind, parallel-group study to either normoxic (NO) or hypoxic (HO) treadmill training, both 3 times/week for 1 h over 4 weeks (Clinicaltrials.gov identifier: NCT02509897). Before and after training, activity energy expenditure (metabolic chamber), maximal workload (incremental treadmill test), walking ability, depressive symptoms (Beck Depression Inventory I), serum erythropoietin concentrations, and immunophenotype of peripheral blood mononuclear cells (PBMCs) were assessed.Results: Energy expenditure did not change due to training in both groups, but was rather fueled by fat than by carbohydrate oxidation after HO training (P = 0.002). Maximal workload increased by 40 Watt and 42 Watt in the NO and HO group, respectively (both P < 0.0001). Distance patients walked in 6 min increased by 25 m and 27 m in the NO and HO group, respectively (NO P = 0.02; HO P = 0.01). Beck Depression Inventory score markedly decreased in both groups (NO P = 0.03; HO P = 0.0003). NO training shifted Treg subpopulations by increasing and decreasing the frequency of CD39+ and CD31+ Tregs, respectively, and decreased IL-17A-producing CD4+ cells. HO training provoked none of these immunological changes. Erythropoietin concentrations were within normal range and did not significantly change in either group.Conclusion: 4 weeks of moderate treadmill training had considerable effects on fitness level and mood in MS patients, both under normoxic and hypoxic conditions. Additionally, NO training improved Th17/Treg profile and HO training improved fatty acid oxidation during exercise. These effects could not be attributed to an increase of erythropoietin.Clinical Trial Registration: ClinicalTrials.gov; NCT02509897; http://www.clinicaltrials.gov
topic multiple sclerosis
hypoxia
endurance training
walking ability
energy metabolism
Tregs
url https://www.frontiersin.org/article/10.3389/fimmu.2018.02819/full
work_keys_str_mv AT anjamahler metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT anjamahler metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT anjamahler metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT andrasbalogh metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT andrasbalogh metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT andrasbalogh metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT andrasbalogh metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT ilonacsizmadia metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT larsklug metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT larsklug metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT markuskleinewietfeld metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT jochensteiniger metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT ursasusnjar metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT ursasusnjar metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT dominiknmuller metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT dominiknmuller metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT dominiknmuller metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT dominiknmuller metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT michaelboschmann metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT michaelboschmann metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT friedemannpaul metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT friedemannpaul metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
AT friedemannpaul metabolicmentalandimmunologicaleffectsofnormoxicandhypoxictraininginmultiplesclerosispatientsapilotstudy
_version_ 1716822179707879424
spelling doaj-2c7e662b810a44f0a1148c6a909cf7062020-11-24T20:42:27ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-11-01910.3389/fimmu.2018.02819392684Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot StudyAnja Mähler0Anja Mähler1Anja Mähler2Andras Balogh3Andras Balogh4Andras Balogh5Andras Balogh6Ilona Csizmadia7Lars Klug8Lars Klug9Markus Kleinewietfeld10Jochen Steiniger11Urša Šušnjar12Urša Šušnjar13Dominik N. Müller14Dominik N. Müller15Dominik N. Müller16Dominik N. Müller17Michael Boschmann18Michael Boschmann19Friedemann Paul20Friedemann Paul21Friedemann Paul22Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyBerlin Institute of Health, Berlin, GermanyGerman Centre for Cardiovascular Research Partner Site Berlin, Berlin, GermanyExperimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyBerlin Institute of Health, Berlin, GermanyGerman Centre for Cardiovascular Research Partner Site Berlin, Berlin, GermanyMax Delbruck Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyExperimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyExperimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyBerlin Institute of Health, Berlin, GermanyVIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research Hasselt University, Diepenbeek, BelgiumExperimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyExperimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyInternational Centre for Genetic Engineering and Biotechnology, Triste, ItalyExperimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyBerlin Institute of Health, Berlin, GermanyGerman Centre for Cardiovascular Research Partner Site Berlin, Berlin, GermanyMax Delbruck Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyExperimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyBerlin Institute of Health, Berlin, GermanyExperimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, GermanyBerlin Institute of Health, Berlin, GermanyNeuroCure Clinical Research Center and Department of Neurology, Charité Universitätsmedizin Berlin Humboldt Universität Berlin, Berlin, GermanyBackground: Physical activity might attenuate inflammation and neurodegeneration in multiple sclerosis (MS). Erythropoietin, which is produced upon exposure to hypoxia, is thought to act as a neuroprotective agent in MS. Therefore, we studied the effects of intermittent hypoxic training on activity energy expenditure, maximal workload, serum erythropoietin, and immunophenotype focusing on regulatory and IL-17A-producing T cells.Methods: We assigned 34 relapsing-remitting MS patients within a randomized, single blind, parallel-group study to either normoxic (NO) or hypoxic (HO) treadmill training, both 3 times/week for 1 h over 4 weeks (Clinicaltrials.gov identifier: NCT02509897). Before and after training, activity energy expenditure (metabolic chamber), maximal workload (incremental treadmill test), walking ability, depressive symptoms (Beck Depression Inventory I), serum erythropoietin concentrations, and immunophenotype of peripheral blood mononuclear cells (PBMCs) were assessed.Results: Energy expenditure did not change due to training in both groups, but was rather fueled by fat than by carbohydrate oxidation after HO training (P = 0.002). Maximal workload increased by 40 Watt and 42 Watt in the NO and HO group, respectively (both P < 0.0001). Distance patients walked in 6 min increased by 25 m and 27 m in the NO and HO group, respectively (NO P = 0.02; HO P = 0.01). Beck Depression Inventory score markedly decreased in both groups (NO P = 0.03; HO P = 0.0003). NO training shifted Treg subpopulations by increasing and decreasing the frequency of CD39+ and CD31+ Tregs, respectively, and decreased IL-17A-producing CD4+ cells. HO training provoked none of these immunological changes. Erythropoietin concentrations were within normal range and did not significantly change in either group.Conclusion: 4 weeks of moderate treadmill training had considerable effects on fitness level and mood in MS patients, both under normoxic and hypoxic conditions. Additionally, NO training improved Th17/Treg profile and HO training improved fatty acid oxidation during exercise. These effects could not be attributed to an increase of erythropoietin.Clinical Trial Registration: ClinicalTrials.gov; NCT02509897; http://www.clinicaltrials.govhttps://www.frontiersin.org/article/10.3389/fimmu.2018.02819/fullmultiple sclerosishypoxiaendurance trainingwalking abilityenergy metabolismTregs